Free · No signup · Updated daily
In Brief
Assam approved a ₹600 crore proton beam therapy unit, becoming India's first state to offer advanced radiation therapy in public healthcare.
The Assam State Cabinet, chaired by Chief Minister Himanta Biswa Sarma, approved a budget of ₹600 crore to establish a state-of-the-art Proton Beam Therapy (PBT) unit at the Guwahati Cancer Care Centre. With this clearance, Assam becomes the first state in India to offer highly advanced proton beam radiation therapy within the public healthcare sector, significantly improving access to specialized cancer care in Northeast India.
Proton Beam Therapy is an advanced form of precise radiotherapy that uses high-energy proton beams instead of traditional X-rays (photons) to destroy cancer cells. Because protons release the majority of their radiation dose directly within the tumor target (known as the 'Bragg Peak') with minimal entry and exit doses, surrounding healthy tissues suffer significantly less radiation damage compared to conventional radiation techniques.
Key facts for examinees: The project budget stands at ₹600 crore. Until now, PBT technology in India was largely restricted to premier private institutes like Apollo Cancer Centre in Chennai. Establishing this facility under public healthcare makes high-cost radiation therapy affordable for non-affluent patients across the northeastern region.
This initiative serves as a major milestone for healthcare infrastructure development and public health policy in India. For exam aspirants, this news aligns with UPSC Mains GS-3 Science & Technology (Biomedical Applications) and Prelims general science questions covering advanced medical technologies and cancer treatment modalities.
Public Health Experts Advocate Typhoid Vaccine Integration into Immunization Schedule
31 Aug 2026
Medical Experts Demand Human Oversight in AI Healthcare Integration Across Hospitals
30 Aug 2026
NPCIL Plans New Design Unit to Support Private Sector Nuclear Players
27 Aug 2026
Meiji Seika and Serum Institute Partner to Produce Japanese Encephalitis Vaccine
25 Aug 2026